Personal information

No personal information available

Activities

Collapse all

Works (44)

Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

Clinical Cancer Research
2023-04-14 | Journal article
DOI: 10.1158/1078-0432.CCR-22-0890
Contributors: Younes Belkouchi; Hugues Talbot; Nathalie Lassau; Littisha Lawrance; Siham Farhane; Rahma Feki-Mkaouar; Joya Hadchiti; Lama Dawi; Julien Vibert; Paul-Henry Cournède et al.
Source: check_circle
Crossref

Data from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

2023-04-14 | Preprint
DOI: 10.1158/1078-0432.c.6533077.v2
Contributors: Younes Belkouchi; Hugues Talbot; Nathalie Lassau; Littisha Lawrance; Siham Farhane; Rahma Feki-Mkaouar; Joya Hadchiti; Lama Dawi; Julien Vibert; Paul-Henry Cournède et al.
Source: check_circle
Crossref

Data from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

2023-04-14 | Preprint
DOI: 10.1158/1078-0432.c.6533077
Contributors: Younes Belkouchi; Hugues Talbot; Nathalie Lassau; Littisha Lawrance; Siham Farhane; Rahma Feki-Mkaouar; Joya Hadchiti; Lama Dawi; Julien Vibert; Paul-Henry Cournède et al.
Source: check_circle
Crossref

Supplementary Figure S1 from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

2023-04-14 | Preprint
DOI: 10.1158/1078-0432.22633123.v1
Contributors: Younes Belkouchi; Hugues Talbot; Nathalie Lassau; Littisha Lawrance; Siham Farhane; Rahma Feki-Mkaouar; Joya Hadchiti; Lama Dawi; Julien Vibert; Paul-Henry Cournède et al.
Source: check_circle
Crossref

Supplementary Figure S1 from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

2023-04-14 | Preprint
DOI: 10.1158/1078-0432.22633123
Contributors: Younes Belkouchi; Hugues Talbot; Nathalie Lassau; Littisha Lawrance; Siham Farhane; Rahma Feki-Mkaouar; Joya Hadchiti; Lama Dawi; Julien Vibert; Paul-Henry Cournède et al.
Source: check_circle
Crossref

Supplementary Figure S10 from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

2023-04-14 | Preprint
DOI: 10.1158/1078-0432.22633120
Contributors: Younes Belkouchi; Hugues Talbot; Nathalie Lassau; Littisha Lawrance; Siham Farhane; Rahma Feki-Mkaouar; Joya Hadchiti; Lama Dawi; Julien Vibert; Paul-Henry Cournède et al.
Source: check_circle
Crossref

Supplementary Figure S10 from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

2023-04-14 | Preprint
DOI: 10.1158/1078-0432.22633120.v1
Contributors: Younes Belkouchi; Hugues Talbot; Nathalie Lassau; Littisha Lawrance; Siham Farhane; Rahma Feki-Mkaouar; Joya Hadchiti; Lama Dawi; Julien Vibert; Paul-Henry Cournède et al.
Source: check_circle
Crossref

Supplementary Figure S2 from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

2023-04-14 | Preprint
DOI: 10.1158/1078-0432.22633117.v1
Contributors: Younes Belkouchi; Hugues Talbot; Nathalie Lassau; Littisha Lawrance; Siham Farhane; Rahma Feki-Mkaouar; Joya Hadchiti; Lama Dawi; Julien Vibert; Paul-Henry Cournède et al.
Source: check_circle
Crossref

Supplementary Figure S2 from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

2023-04-14 | Preprint
DOI: 10.1158/1078-0432.22633117
Contributors: Younes Belkouchi; Hugues Talbot; Nathalie Lassau; Littisha Lawrance; Siham Farhane; Rahma Feki-Mkaouar; Joya Hadchiti; Lama Dawi; Julien Vibert; Paul-Henry Cournède et al.
Source: check_circle
Crossref

Supplementary Figure S3 from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

2023-04-14 | Preprint
DOI: 10.1158/1078-0432.22633114.v1
Contributors: Younes Belkouchi; Hugues Talbot; Nathalie Lassau; Littisha Lawrance; Siham Farhane; Rahma Feki-Mkaouar; Joya Hadchiti; Lama Dawi; Julien Vibert; Paul-Henry Cournède et al.
Source: check_circle
Crossref

Supplementary Figure S3 from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

2023-04-14 | Preprint
DOI: 10.1158/1078-0432.22633114
Contributors: Younes Belkouchi; Hugues Talbot; Nathalie Lassau; Littisha Lawrance; Siham Farhane; Rahma Feki-Mkaouar; Joya Hadchiti; Lama Dawi; Julien Vibert; Paul-Henry Cournède et al.
Source: check_circle
Crossref

Supplementary Figure S4 from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

2023-04-14 | Preprint
DOI: 10.1158/1078-0432.22633111.v1
Contributors: Younes Belkouchi; Hugues Talbot; Nathalie Lassau; Littisha Lawrance; Siham Farhane; Rahma Feki-Mkaouar; Joya Hadchiti; Lama Dawi; Julien Vibert; Paul-Henry Cournède et al.
Source: check_circle
Crossref

Supplementary Figure S4 from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

2023-04-14 | Preprint
DOI: 10.1158/1078-0432.22633111
Contributors: Younes Belkouchi; Hugues Talbot; Nathalie Lassau; Littisha Lawrance; Siham Farhane; Rahma Feki-Mkaouar; Joya Hadchiti; Lama Dawi; Julien Vibert; Paul-Henry Cournède et al.
Source: check_circle
Crossref

Supplementary Figure S5 from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

2023-04-14 | Preprint
DOI: 10.1158/1078-0432.22633108.v1
Contributors: Younes Belkouchi; Hugues Talbot; Nathalie Lassau; Littisha Lawrance; Siham Farhane; Rahma Feki-Mkaouar; Joya Hadchiti; Lama Dawi; Julien Vibert; Paul-Henry Cournède et al.
Source: check_circle
Crossref

Supplementary Figure S5 from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

2023-04-14 | Preprint
DOI: 10.1158/1078-0432.22633108
Contributors: Younes Belkouchi; Hugues Talbot; Nathalie Lassau; Littisha Lawrance; Siham Farhane; Rahma Feki-Mkaouar; Joya Hadchiti; Lama Dawi; Julien Vibert; Paul-Henry Cournède et al.
Source: check_circle
Crossref

Supplementary Figure S6 from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

2023-04-14 | Preprint
DOI: 10.1158/1078-0432.22633105.v1
Contributors: Younes Belkouchi; Hugues Talbot; Nathalie Lassau; Littisha Lawrance; Siham Farhane; Rahma Feki-Mkaouar; Joya Hadchiti; Lama Dawi; Julien Vibert; Paul-Henry Cournède et al.
Source: check_circle
Crossref

Supplementary Figure S6 from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

2023-04-14 | Preprint
DOI: 10.1158/1078-0432.22633105
Contributors: Younes Belkouchi; Hugues Talbot; Nathalie Lassau; Littisha Lawrance; Siham Farhane; Rahma Feki-Mkaouar; Joya Hadchiti; Lama Dawi; Julien Vibert; Paul-Henry Cournède et al.
Source: check_circle
Crossref

Supplementary Figure S7 from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

2023-04-14 | Preprint
DOI: 10.1158/1078-0432.22633102
Contributors: Younes Belkouchi; Hugues Talbot; Nathalie Lassau; Littisha Lawrance; Siham Farhane; Rahma Feki-Mkaouar; Joya Hadchiti; Lama Dawi; Julien Vibert; Paul-Henry Cournède et al.
Source: check_circle
Crossref

Supplementary Figure S7 from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

2023-04-14 | Preprint
DOI: 10.1158/1078-0432.22633102.v1
Contributors: Younes Belkouchi; Hugues Talbot; Nathalie Lassau; Littisha Lawrance; Siham Farhane; Rahma Feki-Mkaouar; Joya Hadchiti; Lama Dawi; Julien Vibert; Paul-Henry Cournède et al.
Source: check_circle
Crossref

Supplementary Figure S8 from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

2023-04-14 | Preprint
DOI: 10.1158/1078-0432.22633099
Contributors: Younes Belkouchi; Hugues Talbot; Nathalie Lassau; Littisha Lawrance; Siham Farhane; Rahma Feki-Mkaouar; Joya Hadchiti; Lama Dawi; Julien Vibert; Paul-Henry Cournède et al.
Source: check_circle
Crossref

Supplementary Figure S8 from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

2023-04-14 | Preprint
DOI: 10.1158/1078-0432.22633099.v1
Contributors: Younes Belkouchi; Hugues Talbot; Nathalie Lassau; Littisha Lawrance; Siham Farhane; Rahma Feki-Mkaouar; Joya Hadchiti; Lama Dawi; Julien Vibert; Paul-Henry Cournède et al.
Source: check_circle
Crossref

Supplementary Figure S9 from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

2023-04-14 | Preprint
DOI: 10.1158/1078-0432.22633096
Contributors: Younes Belkouchi; Hugues Talbot; Nathalie Lassau; Littisha Lawrance; Siham Farhane; Rahma Feki-Mkaouar; Joya Hadchiti; Lama Dawi; Julien Vibert; Paul-Henry Cournède et al.
Source: check_circle
Crossref

Supplementary Figure S9 from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

2023-04-14 | Preprint
DOI: 10.1158/1078-0432.22633096.v1
Contributors: Younes Belkouchi; Hugues Talbot; Nathalie Lassau; Littisha Lawrance; Siham Farhane; Rahma Feki-Mkaouar; Joya Hadchiti; Lama Dawi; Julien Vibert; Paul-Henry Cournède et al.
Source: check_circle
Crossref

Data from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

2023-04-01 | Preprint
DOI: 10.1158/1078-0432.c.6533077.v1
Contributors: Younes Belkouchi; Hugues Talbot; Nathalie Lassau; Littisha Lawrance; Siham Farhane; Rahma Feki-Mkaouar; Joya Hadchiti; Lama Dawi; Julien Vibert; Paul-Henry Cournède et al.
Source: check_circle
Crossref

Supplementary Figure S1 from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

2023-04-01 | Preprint
DOI: 10.1158/1078-0432.22489990
Contributors: Younes Belkouchi; Hugues Talbot; Nathalie Lassau; Littisha Lawrance; Siham Farhane; Rahma Feki-Mkaouar; Joya Hadchiti; Lama Dawi; Julien Vibert; Paul-Henry Cournède et al.
Source: check_circle
Crossref

Supplementary Figure S1 from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

2023-04-01 | Preprint
DOI: 10.1158/1078-0432.22489990.v1
Contributors: Younes Belkouchi; Hugues Talbot; Nathalie Lassau; Littisha Lawrance; Siham Farhane; Rahma Feki-Mkaouar; Joya Hadchiti; Lama Dawi; Julien Vibert; Paul-Henry Cournède et al.
Source: check_circle
Crossref

Supplementary Figure S10 from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

2023-04-01 | Preprint
DOI: 10.1158/1078-0432.22489987
Contributors: Younes Belkouchi; Hugues Talbot; Nathalie Lassau; Littisha Lawrance; Siham Farhane; Rahma Feki-Mkaouar; Joya Hadchiti; Lama Dawi; Julien Vibert; Paul-Henry Cournède et al.
Source: check_circle
Crossref

Supplementary Figure S10 from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

2023-04-01 | Preprint
DOI: 10.1158/1078-0432.22489987.v1
Contributors: Younes Belkouchi; Hugues Talbot; Nathalie Lassau; Littisha Lawrance; Siham Farhane; Rahma Feki-Mkaouar; Joya Hadchiti; Lama Dawi; Julien Vibert; Paul-Henry Cournède et al.
Source: check_circle
Crossref

Supplementary Figure S2 from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

2023-04-01 | Preprint
DOI: 10.1158/1078-0432.22489984.v1
Contributors: Younes Belkouchi; Hugues Talbot; Nathalie Lassau; Littisha Lawrance; Siham Farhane; Rahma Feki-Mkaouar; Joya Hadchiti; Lama Dawi; Julien Vibert; Paul-Henry Cournède et al.
Source: check_circle
Crossref

Supplementary Figure S2 from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

2023-04-01 | Preprint
DOI: 10.1158/1078-0432.22489984
Contributors: Younes Belkouchi; Hugues Talbot; Nathalie Lassau; Littisha Lawrance; Siham Farhane; Rahma Feki-Mkaouar; Joya Hadchiti; Lama Dawi; Julien Vibert; Paul-Henry Cournède et al.
Source: check_circle
Crossref

Supplementary Figure S3 from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

2023-04-01 | Preprint
DOI: 10.1158/1078-0432.22489981.v1
Contributors: Younes Belkouchi; Hugues Talbot; Nathalie Lassau; Littisha Lawrance; Siham Farhane; Rahma Feki-Mkaouar; Joya Hadchiti; Lama Dawi; Julien Vibert; Paul-Henry Cournède et al.
Source: check_circle
Crossref

Supplementary Figure S3 from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

2023-04-01 | Preprint
DOI: 10.1158/1078-0432.22489981
Contributors: Younes Belkouchi; Hugues Talbot; Nathalie Lassau; Littisha Lawrance; Siham Farhane; Rahma Feki-Mkaouar; Joya Hadchiti; Lama Dawi; Julien Vibert; Paul-Henry Cournède et al.
Source: check_circle
Crossref

Supplementary Figure S4 from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

2023-04-01 | Preprint
DOI: 10.1158/1078-0432.22489978.v1
Contributors: Younes Belkouchi; Hugues Talbot; Nathalie Lassau; Littisha Lawrance; Siham Farhane; Rahma Feki-Mkaouar; Joya Hadchiti; Lama Dawi; Julien Vibert; Paul-Henry Cournède et al.
Source: check_circle
Crossref

Supplementary Figure S4 from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

2023-04-01 | Preprint
DOI: 10.1158/1078-0432.22489978
Contributors: Younes Belkouchi; Hugues Talbot; Nathalie Lassau; Littisha Lawrance; Siham Farhane; Rahma Feki-Mkaouar; Joya Hadchiti; Lama Dawi; Julien Vibert; Paul-Henry Cournède et al.
Source: check_circle
Crossref

Supplementary Figure S5 from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

2023-04-01 | Preprint
DOI: 10.1158/1078-0432.22489975.v1
Contributors: Younes Belkouchi; Hugues Talbot; Nathalie Lassau; Littisha Lawrance; Siham Farhane; Rahma Feki-Mkaouar; Joya Hadchiti; Lama Dawi; Julien Vibert; Paul-Henry Cournède et al.
Source: check_circle
Crossref

Supplementary Figure S5 from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

2023-04-01 | Preprint
DOI: 10.1158/1078-0432.22489975
Contributors: Younes Belkouchi; Hugues Talbot; Nathalie Lassau; Littisha Lawrance; Siham Farhane; Rahma Feki-Mkaouar; Joya Hadchiti; Lama Dawi; Julien Vibert; Paul-Henry Cournède et al.
Source: check_circle
Crossref

Supplementary Figure S6 from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

2023-04-01 | Preprint
DOI: 10.1158/1078-0432.22489972.v1
Contributors: Younes Belkouchi; Hugues Talbot; Nathalie Lassau; Littisha Lawrance; Siham Farhane; Rahma Feki-Mkaouar; Joya Hadchiti; Lama Dawi; Julien Vibert; Paul-Henry Cournède et al.
Source: check_circle
Crossref

Supplementary Figure S6 from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

2023-04-01 | Preprint
DOI: 10.1158/1078-0432.22489972
Contributors: Younes Belkouchi; Hugues Talbot; Nathalie Lassau; Littisha Lawrance; Siham Farhane; Rahma Feki-Mkaouar; Joya Hadchiti; Lama Dawi; Julien Vibert; Paul-Henry Cournède et al.
Source: check_circle
Crossref

Supplementary Figure S7 from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

2023-04-01 | Preprint
DOI: 10.1158/1078-0432.22489969
Contributors: Younes Belkouchi; Hugues Talbot; Nathalie Lassau; Littisha Lawrance; Siham Farhane; Rahma Feki-Mkaouar; Joya Hadchiti; Lama Dawi; Julien Vibert; Paul-Henry Cournède et al.
Source: check_circle
Crossref

Supplementary Figure S7 from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

2023-04-01 | Preprint
DOI: 10.1158/1078-0432.22489969.v1
Contributors: Younes Belkouchi; Hugues Talbot; Nathalie Lassau; Littisha Lawrance; Siham Farhane; Rahma Feki-Mkaouar; Joya Hadchiti; Lama Dawi; Julien Vibert; Paul-Henry Cournède et al.
Source: check_circle
Crossref

Supplementary Figure S8 from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

2023-04-01 | Preprint
DOI: 10.1158/1078-0432.22489966
Contributors: Younes Belkouchi; Hugues Talbot; Nathalie Lassau; Littisha Lawrance; Siham Farhane; Rahma Feki-Mkaouar; Joya Hadchiti; Lama Dawi; Julien Vibert; Paul-Henry Cournède et al.
Source: check_circle
Crossref

Supplementary Figure S8 from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

2023-04-01 | Preprint
DOI: 10.1158/1078-0432.22489966.v1
Contributors: Younes Belkouchi; Hugues Talbot; Nathalie Lassau; Littisha Lawrance; Siham Farhane; Rahma Feki-Mkaouar; Joya Hadchiti; Lama Dawi; Julien Vibert; Paul-Henry Cournède et al.
Source: check_circle
Crossref

Supplementary Figure S9 from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

2023-04-01 | Preprint
DOI: 10.1158/1078-0432.22489963
Contributors: Younes Belkouchi; Hugues Talbot; Nathalie Lassau; Littisha Lawrance; Siham Farhane; Rahma Feki-Mkaouar; Joya Hadchiti; Lama Dawi; Julien Vibert; Paul-Henry Cournède et al.
Source: check_circle
Crossref

Supplementary Figure S9 from Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy

2023-04-01 | Preprint
DOI: 10.1158/1078-0432.22489963.v1
Contributors: Younes Belkouchi; Hugues Talbot; Nathalie Lassau; Littisha Lawrance; Siham Farhane; Rahma Feki-Mkaouar; Joya Hadchiti; Lama Dawi; Julien Vibert; Paul-Henry Cournède et al.
Source: check_circle
Crossref
How many people are using ORCID?